GlassScriptPhysician profile
Joseph V Davis
NPI 1689781445
$2,047.89
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $161 · 2020: $13.06 · 2021: $478 · 2022: $209 · 2023: $984 · 2024: $204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,187.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,187.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $316.07 | 2019-2024 | Collagenase Santyl |
| Medtronic, INC. | $290.14 | 2021-2023 | Signia |
| Teleflex LLC | $260.04 | 2023 | Quikclot |
| Integra Lifesciences Corporation | $215.29 | 2022-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kci USA, INC. | $159.19 | 2019-2023 | Prevena |
| Medline Industries LP | $156.81 | 2021 | |
| Solventum Corporation | $144.81 | 2024 | V.A.C. Veraflo, Prevena |
| Innovation Technologies INC | $135.01 | 2023 | Irrisept |
| Kerecis Limited | $125.01 | 2021 | |
| Zimmer Biomet Holdings, INC. | $101.15 | 2019 | |
| Conmed Corporation | $73.31 | 2022 | |
| Ethicon US, LLC | $58.00 | 2021 | |
| Davol INC. | $13.06 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.